Eagle Veterinary Technology Co.Ltd.

As of March 31, 2026, Eagle Veterinary Technology Co.Ltd. carries a market capitalization of 46.64B, placing it among publicly traded companies globally. Its enterprise value stands at 41.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Eagle Veterinary Technology Co.Ltd. has 12.27M shares outstanding.

As of March 31, 2026, Eagle Veterinary Technology Co.Ltd. trades at a trailing price-to-earnings ratio of 10.76. The price-to-sales ratio is 1.07, and the price-to-book ratio stands at 0.89.

As of March 31, 2026, Eagle Veterinary Technology Co.Ltd. trades at an EV/EBITDA multiple of 7.22 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.95 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 9.54 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Eagle Veterinary Technology Co.Ltd. trades at an EV/FCF ratio of 12.25, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 41.60B versus a market cap of 46.64B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Eagle Veterinary Technology Co.Ltd. maintains a current ratio of 3.41, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.40, indicating elevated leverage, while an interest coverage ratio of 22.77 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Eagle Veterinary Technology Co.Ltd. posted a return on equity (ROE) of 8.56, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 7.14 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.82, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.94, useful for judging operating efficiency across full business cycles. The company generates approximately 396.46M in revenue per employee across its workforce of 110.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.64 indicates how many times Eagle Veterinary Technology Co.Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Eagle Veterinary Technology Co.Ltd. recorded 589.43M in income tax expense. That works out to an effective tax rate of 11.97, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 4.92B, leaving 4.33B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Eagle Veterinary Technology Co.Ltd.'s stock has declined approximately 29.07% over the past 52 weeks. The 50-day moving average sits at 3,106.00, while the 200-day moving average is 3,548.28.

Over the twelve months ended March 31, 2026, Eagle Veterinary Technology Co.Ltd. generated 43.61B in revenue and converted that into 4.33B in net income, yielding earnings per share of 353.11. EBITDA reached 5.76B, while operating income came in at 4.46B.

As of March 31, 2026, Eagle Veterinary Technology Co.Ltd. holds 11.54B in cash and equivalents against 6.49B in total debt, resulting in a net debt position of -175.06M. Total book value stands at 52.38B, with working capital of 22.88B providing operational flexibility.

Eagle Veterinary Technology Co.Ltd. produced 4.81B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -1.64B in capital expenditures, free cash flow totaled 3.17B - equivalent to 258.38 per share.

Over the twelve months ended March 31, 2026, Eagle Veterinary Technology Co.Ltd. posted a gross margin of 34.24, reflecting its pricing power and cost economics. The operating margin of 10.23 and net profit margin of 9.94 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Eagle Veterinary Technology Co.Ltd. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.80, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.43, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Eagle Veterinary Technology Co.Ltd. shareholders.

Eagle Veterinary Technology Co.Ltd.'s most recent stock split took place on September 22, 2014.

As of March 31, 2026, Eagle Veterinary Technology Co.Ltd. has an Altman Z-Score of 4.10, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.